gemfibrozil and bay 94-8862

gemfibrozil has been researched along with bay 94-8862 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Engelen, A; Gerisch, M; Heinig, R; Loewen, S; Nagelschmitz, J	1

Trials

1 trial(s) available for gemfibrozil and bay 94-8862

Article	Year
Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug-Drug Interaction Studies In Vitro and In Vivo. European journal of drug metabolism and pharmacokinetics, 2018, Volume: 43, Issue:6 Topics: Adult; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Gastric Mucosa; Gemfibrozil; Hepatocytes; Humans; In Vitro Techniques; Liver; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Naphthyridines; Verapamil; Young Adult	2018

Article

Year

Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug-Drug Interaction Studies In Vitro and In Vivo.

European journal of drug metabolism and pharmacokinetics, 2018, Volume: 43, Issue:6

Topics: Adult; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Gastric Mucosa; Gemfibrozil; Hepatocytes; Humans; In Vitro Techniques; Liver; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Naphthyridines; Verapamil; Young Adult

2018